Merck’s Strong Q2 Overshadowed By Gardasil Sales Decline In China

Revenue Guidance Raised, EPS Expectation Lowered

 
• By Mandy Jackson

Merck & Co.’s $16.11bn in sales exceeded expectations and prompted a slight increase in 2024 guidance, but HPV vaccine Gardasil came in slightly below consensus due to lower sales in China.

Merck sign atop Merck Research Laboratories campus in South San Francisco
Merck expects up to $64.4bn in full-year 2024 sales • Source: Shutterstock

More from Business

More from Scrip